Ping An Earnings: Chinese Insurer Beats Expectations for New Business Value

""
Securities in This Article
Ping An Insurance (Group) Co. of China Ltd Class A
(601318)

Ping An Insurance 601318 reported first-quarter total revenue and net profit rose 31% and 49% year on year, respectively, as it adopted IFRS 17. Its H shares surged 9% on April 27 following the results, boosted by optimism for the outlooks after new business value, or NBV, grew 8.8% year on year, the first positive growth in NBV since 2020. If we exclude the impact of changes in actuarial assumptions, adjusted NBV growth would have been 21% year on year, stronger still.

Although the stock market’s reaction was positive, we see Ping An’s results as largely in line with our expectation for around 10% growth in full-year NBV. Thus, we leave our earnings assumptions and our fair value estimates at CNY 60 per A share and HKD 66 per H share unchanged. H shares are undervalued relative to our fair value, trading at 0.7 times 2023 forecast embedded value.

Management noted that first-quarter agent productivity improved 37% year on year, while agent headcount was down a further 9% versus the end of 2022. NBV from the bancassurance channel surged 130% from the year-ago period. We believe Ping An’s three-year life insurance reform has begun to bear fruit and expect NBV margin to modestly improve in coming quarters thanks to gradual product mix shift toward protection-type products and low base in the second half of 2022.

The 49% year-on-year net profit growth under the adoption of new accounting rules was primarily driven by better investment return, while operating profit after tax, or OPAT, declined 3.4% year on year on a 2% contraction in the life insurance segment. We believe the divergence between net profit growth and OPAT contraction is partly due to the lagging impact of a sharp contraction in NBV in 2022 that significantly dragged down contractual service margin.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

Sponsor Center